🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Original Article: Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer (TAILORx) nej.md/2JkWbEu #ASCO18

Phase III trial: People with surgically removed pancreatic cancer who received mFOLFIRINOX chemo lived a median of 20 months longer than those who received gemcitabine bit.ly/2JcgHnh #ASCO18

PRODIGE 7 : HIPEC added to cytoreductive surgery for isolated CRC peritoneal mets does not improve OS and increases late post-op complications

Can we improve surgical outcomes by promoting exercise, nutrition, and lifestyle modifications prior to major operations? Sunnybrook Health Sciences Centre team has created a #prehab program for cancer patients Cancer Care Ontario - now Ontario Health ncbi.nlm.nih.gov/pubmed/29862453

Individualized post-op management w/ e-health using patient reported outcomes, a RCT The Lancet thelancet.com/journals/lance… thelancet.com/journals/lance…

Cancer-related fatigue (CRF) is increasingly recognised as one of the most common and distressing side effects of cancer and its treatments. It has a negative impact on work, social... powerfulpatients.org/2017/08/22/how…

An assessment of 23,840 Stage I-III breast cancer patients shows high rates of symptom burden, especially in younger women, more advanced stage, lower income patients. Can we use this data to improve symptoms during treatment? authors.elsevier.com/a/1XNhN3QE--DQ…

Incorporating Patient Preferences in Non-inferiority Trials: Our proposal to improve the clinical utility and interpretation of non-inferiority trials JAMA Nancy Baxter MD PhD @tyler_chesney U of T Department of Surgery jamanetwork.com/journals/jama/…

Important info on pt-reported symptom burden after #NET diagnosis now in The Oncologist. Frequent symptoms and burden persists over 5y. Now, need to use this data to ⬆️ early & longitudinal supportive care 🦓 CNETS Supported by NANETS IRSC onlinelibrary.wiley.com/doi/abs/10.163…

Our study in AATS Journals looking at esophagectomy readmissions in Ontario: 1. No change in readmission rate over 13 yrs 2. Same at thoracic & non-thoracic centres 3. 18% readmitted at 'best' centre Not all readmissions are 'bad' doi.org/10.1016/j.jtcv… #tssmn #SoMe4Surgery

Congratulations Nivethan Vela on his GOLDEN STETHOSCOPE AWARD!! An Outstanding Temerty Medicine #medstudent in the Peters-Boyd Academy Sunnybrook Health Sciences Centre!! Great work presented Society of Surgical Oncology on costs/benefits of adjuvant therapy for #pancreascancer-should be published soon!

New ICES study led by Lev Bubis & Alyson Mahar looked at patient-reported symptom severity among 22,650 cancer outpatients in the last 6 months of life sciencedirect.com/science/articl…

PATCH-DP: a single-arm phase II trial of intra-operative application of HEMOPATCH™ to the pancreatic stump to preve… pubmed.ncbi.nlm.nih.gov/34176743/

#GI22 📢Before the meeting gets rolling, I would like to present the abstracts I am keeping my eye👁️on My Top 10(ish) #PancreaticCancer abstracts and My Top 10 non-pancreatic abstracts

A short history (14 slides) of adjuvant therapy for pancreatic cancer #TheAmylaseSchool #HiloAEG #UEGambassador #GItwitter EPC-Europ Pancr Club YOUPPIE Pancreas @maloehr1 Gabriele Capurso MD, PhD🇺🇦 #PancreaticCancer 👇👇👇

Laura Davis from Natalie Coburn's team presenting research on province-wide cancer patient-reported outcomes data at CCO Research Day 2018! ICES Sunnybrook Health Sciences Centre #PROs #CancerResearch

Congratulations to Natalie Coburn! So very well-deserved! x.com/ShadyAshamalla…

Congratulations to Yunni Jeong for her Best Presentation Award at the 2018 Korean Gastric Cancer Association meeting! U of T Department of Surgery MyGutFeeling-Stomach Cancer Foundation of Canada

Immunoscore for the classification of #coloncancer: study provides a reliable estimate of the risk of recurrence in patients with colon cancer Society for Immunotherapy of Cancer hubs.ly/H0c2fLc0